Doctor Preston Mason

Doctor Preston Mason

Brigham and Women's Hospital, Harvard Medical School, Boston (United States of America)

Member of:

Dr. R. Preston Mason is a faculty member of the Cardiovascular Division at Brigham and Women’s Hospital and Harvard Medical School in Boston, Massachusetts, USA. Dr Mason is also President and Founder of Elucida Research. He has received many awards for his research in cardiovascular pharmacology and teaching over the past 30 years, including an honorary doctorate in science. He received a full scholarship for graduate and medical programs (MD/PhD) at the University of Connecticut School of Medicine. Prior to coming to Boston, he was on the faculties of the University of Connecticut School of Medicine and the Medical College of Pennsylvania (now Drexel University) where he was nominated for full professor. Dr. Mason has authored or co-authored more than 250 scientific articles and abstracts.

Presentations Articles

Eicosapentaenoic acid (EPA) inhibited lipoprotein(a) [Lp(a)] oxidation and its effects on expression of oxidative stress and pro-inflammatory proteins in endothelial cells

Event: ESC Congress 2025

Topic: Lipids, Metabolism

Session: Targeting lipoprotein-driven inflammation and oxidative stress in cardiovascular disease

Access

Atorvastatin active metabolite inhibits oxidation of Lp(a), small dense LDL and triglyceride-rich lipoproteins compared to other statins through a free radical scavenging mechanism

Event: ESC Congress 2025

Topic: Lipids, Metabolism

Session: Targeting lipoprotein-driven inflammation and oxidative stress in cardiovascular disease

Access

High glucose enhanced lipoprotein(a) [Lp(a)] oxidation in a manner inhibited by eicosapentaenoic acid (EPA) in vitro

Event: ESC Congress 2024

Topic: Lipid Metabolism, Metabolic Syndrome, Diabetes

Session: Lipids: new pathophysiological and therapeutic insights

Access

Omega-3 fatty acids differentially reduced expression of neutrophil degranulation-associated proteins in endothelial cells during IL-6 exposure

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids, Metabolism

Session: Basic science e-posters

Access

Eicosapentaenoic acid inhibits lipopolysaccharide (LPS)-induced nitrite production and cytokine release from J774 macrophages

Event: ESC Congress 2021 - The Digital Experience

Topic: Leukocytes, Inflammation, Immunity

Session: Basic science e-posters

Access

Omega-3 fatty acids differentially alter the expression of detoxification enzymes and nitric oxide bioavailability in endothelial cells during IL-6 exposure

Event: ESC Congress 2021 - The Digital Experience

Topic: Lipids, Metabolism

Session: Basic science e-posters

Access

Omega-3 fatty acids - Why they are not all the same?

Event: ESC Congress 2019

Topic: Risk Factors and Prevention, Other

Session: Residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice

Access

Omega-3 fatty acids - Why they are not all the same?

Event: ESC Congress 2019

Topic: Risk Factors and Prevention, Other

Session: Reducing residual risk for cardiovascular disease - Omega-3 fatty acids in cardiology practice

Access

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources

Explore sponsored resources

Doctor Preston Mason

Biography

Contributor content

Eicosapentaenoic acid (EPA) inhibited lipoprotein(a) [Lp(a)] oxidation and its effects on expression of oxidative stress and pro-inflammatory proteins in endothelial cells

Atorvastatin active metabolite inhibits oxidation of Lp(a), small dense LDL and triglyceride-rich lipoproteins compared to other statins through a free radical scavenging mechanism

High glucose enhanced lipoprotein(a) [Lp(a)] oxidation in a manner inhibited by eicosapentaenoic acid (EPA) in vitro

Omega-3 fatty acids differentially reduced expression of neutrophil degranulation-associated proteins in endothelial cells during IL-6 exposure

Eicosapentaenoic acid inhibits lipopolysaccharide (LPS)-induced nitrite production and cytokine release from J774 macrophages

Omega-3 fatty acids differentially alter the expression of detoxification enzymes and nitric oxide bioavailability in endothelial cells during IL-6 exposure

Omega-3 fatty acids - Why they are not all the same?

Omega-3 fatty acids - Why they are not all the same?

ESC 365 is supported by

Doctor Preston Mason Follow

Biography

Contributor content

Eicosapentaenoic acid (EPA) inhibited lipoprotein(a) [Lp(a)] oxidation and its effects on expression of oxidative stress and pro-inflammatory proteins in endothelial cells

Atorvastatin active metabolite inhibits oxidation of Lp(a), small dense LDL and triglyceride-rich lipoproteins compared to other statins through a free radical scavenging mechanism

High glucose enhanced lipoprotein(a) [Lp(a)] oxidation in a manner inhibited by eicosapentaenoic acid (EPA) in vitro

Omega-3 fatty acids differentially reduced expression of neutrophil degranulation-associated proteins in endothelial cells during IL-6 exposure

Eicosapentaenoic acid inhibits lipopolysaccharide (LPS)-induced nitrite production and cytokine release from J774 macrophages

Omega-3 fatty acids differentially alter the expression of detoxification enzymes and nitric oxide bioavailability in endothelial cells during IL-6 exposure

Omega-3 fatty acids - Why they are not all the same?

Omega-3 fatty acids - Why they are not all the same?

ESC 365 is supported by

Doctor Preston Mason